1. Working Together to Diagnose Idiopathic Pulmonary Fibrosis

3. Idiopathic Pulmonary Fibrosis (IPF)

4. Impact of IPF

5. Consequences of Missing a Diagnosis of IPF

6. Early Diagnosis of IPF Is Important to Improve Long-Term Treatment Outcomes

7. Early Diagnosis of IPF – Expert Perspective

8. Diagnosis of IPF: Start With Excluding Other Forms of ILD

9. Diagnosis of IPF: Key Assessments

10. IPF Diagnosis: HRCT as a 'Gatekeeper' in Initial Patient Evaluation

11. HRCT Patterns and the Diagnosis of IPF: UIP and Probable UIP

12. HRCT Patterns and the Diagnosis of IPF: Indeterminate for UIP and Alternative Diagnosis

13. 'Indeterminate for UIP' Remains a Challenge

14. Diagnosis of IPF: Guideline Updates (1 of 2)

15. Diagnosis of IPF: Guideline Updates (2 of 2)

16. When Is Histopathology Necessary?

17. Selection of Patients in Need of a Surgical Lung Biopsy Is Key

18. Transbronchial Lung Cryobiopsy

19. BAL in Patients Suspected to Have IPF -- Expert Perspective

20. Histopathology Patterns for IPF Diagnosis

21. Diagnosis Based on HRCT and Histopathology Patterns

22. Diagnostic Algorithm for IPF

23. Key Challenges in the Diagnosis of IPF -- Expert Perspective

24. Diagnosis in Patients Who Should Have but Are Unable to Undergo Lung Biopsy

25. Misdiagnosis and Diagnostic Delay in Patients With ILD

26. Modest Interobserver Agreement in UIP Diagnosis Categories by HRCT, Regardless of Experience Level

27. MDD for the Diagnosis of Patients With IPF

28. Agreement Among MDD Teams Is Good and (Non-Significantly) Better than Agreement Among Individual Specialties

29. Key Points to Communicate to Patients Diagnosed With IPF

30. Concluding Remarks

31. Abbreviations